EnlivenHealth Celebrates American Pharmacists Month » Learn More

EnlivenHealth Weekly Recap | April 19th, 2025

Here are the top stories from the last week:

Industry Updates

Alliance to End Hunger Joins NACDS’ Nourish My Health Campaign
The National Association of Chain Drug Stores announced that the Alliance to End Hunger has joined as a national partner in NACDS’ “Nourish My Health” public health campaign. The campaign focuses on the role of nutrition in health and aims to reach millions across the U.S., particularly in areas with high diet-related disease risks.
Read article »

Morris & Dickson Partners with Mark Cuban Cost Plus Drugs
Morris & Dickson is partnering with Mark Cuban Cost Plus Drug Company to expand access to injectable medications, aiming to mitigate drug shortages and improve affordability and accessibility for healthcare providers.
Read article »

AAM comments on Section 232 Investigation on Pharmaceuticals
The Association for Accessible Medicines commented on a Section 232 investigation into tariffs on pharmaceuticals, warning that tariffs could worsen drug shortages and hinder patient access.
Read article »

CVS Issues Statement to Arkansas Bill Preventing PBMs from Owning Pharmacies
CVS argues that the bill will reduce access to pharmacy care, increase prescription drug spending, and result in job losses in Arkansas.
Read article »

APA, NCPA Cheer First-Of-Its-Kind State Law Banning PBMs from Owning Pharmacies
Arkansas Governor Sarah Huckabee Sanders signed HB 1150 into law, prohibiting state permits to pharmacies owned by PBMs, effective January 1, 2026. This legislation is seen as a model for other states and the federal government. The NCPA and Arkansas Pharmacists Association (APA) supported the bill, which aims to end anticompetitive practices by PBMs and improve access to quality pharmacy care.
Read article »

President Trump Signs Executive Order to Lower Rx Prices
President Trump signed an executive order directing the Department of Health and Human Services to reduce prescription drug prices, aiming to improve Medicare drug pricing and increase the availability of generics.
Read article »

Community Pharmacies Actively Advance Clinical Trial Access
This article discusses how community pharmacies are playing a crucial role in advancing access to clinical trials by utilizing their skills in data collection, analysis, and interpretation.
Read article »

Drug & Technology Updates

FDA Grants Interchangeable Designation for Celltrion’s Yuflyma
The FDA has designated Celltrion’s Yuflyma as an interchangeable biosimilar to Humira, which could increase patient access to this therapy.
Read article »

Biocon Biologics Secures Market Entry Date for Eylea Biosimilar
Biocon Biologics has reached an agreement to launch its Eylea biosimilar, Yesafili, in the U.S. by 2026, expanding its presence in the ophthalmology market.
Read article »

ACIP Votes to Expand Lowering RSV Vaccine Recommendation Age to 50 for High-Risk Adults
The article discusses the Advisory Committee on Immunization Practices (ACIP) voting to lower the recommended age for RSV vaccination to 50 for high-risk adults, though the recommendations are not final until published in the Morbidity and Mortality Weekly Report.
Read article »

siRNA-Based MIR 19 Reduces Progression to Severe Disease in Outpatients with Mild COVID-19
This article highlights a new treatment, MIR 19, which uses small interfering RNA (siRNA) to directly target viral replication, potentially revolutionizing outpatient COVID-19 treatment.
Read article »

Eli Lilly Says New GLP-1 Pill for Diabetes and Weight Loss Effective in Study, Will Seek FDA Approval
Eli Lilly’s new GLP-1 pill has completed a successful Phase 3 trial, showing significant reductions in A1C levels, and the company plans to seek FDA approval.
Read article »

Pharmaceutical Clinical Study to Accelerate FDA Approval of SmartTrack
The SmartTrack initiative aims to streamline the approval process for generic drugs, potentially reducing the need for extensive clinical studies.
Read article »

Swisslog Healthcare Unveils New Pharmacy Tech
Swisslog Healthcare introduces AutoPack, a technology capable of packaging up to 480 medications, enhancing pharmacy operations.
Read article »

X

Amplicare is now part of EnlivenHealth®

X

FDSRX is now part of EnlivenHealth®